Intelligent Medicine Acquisition Overview
Get informed when a big investor buys or sells
+ Follow22.53
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
The latest P/E ratio for IQMD is 22.53. That is below the sector sector average of 22.73. Investors often review this figure alongside Intelligent Medicine Acquisition's historical trend and sector peers before judging valuation or financial health.
Against its sector companies, IQMD currently prints 22.53 for P/E ratio, while the sector average sits near 22.73. That is roughly 0.9% below the sector mean. Large gaps often invite a closer look at Intelligent Medicine Acquisition's growth, margins, and balance sheet.
A P/E ratio of 22.53 for Intelligent Medicine Acquisition is not 'good' or 'bad' on its own. Compare it with the peer average (22.73) and with IQMD's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.
After noting IQMD's P/E ratio (22.53), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.
